This resolution supports reopening the U.S. Capitol Building and House Office Buildings to visitors under the public visitation policies that were in place before the COVID-19 pandemic.
This resolution expresses the sense of the House of Representatives that the International Olympic Committee (IOC) should remove from the International Olympic Committee Executive Board certain countries that are subject to sanctions for human rights violations and bars such countries from participating in the IOC's decision-making processes.
This resolution addresses the need for improvements to broadband infrastructure, particularly in rural areas, and the role of specified federal agencies in making such improvements.
This resolution requests the President and directs the Department of Homeland Security (DHS) to transmit to the House of Representatives, no later than 14 days after the date of the adoption of this resolution, copies of certain documents and other materials, both classified and unclassified, in the possession of the President or DHS as of the date of adoption of this resolution that refer or relate to certain aspects on border policy, particularly along the southwestern border.
Securing Transparent Operations to Prevent China's Abuse of International Financing Act or the STOP China's Abuse of International Financing Act This bill requires U.S. representatives to the United Nations, the World Trade Organization, and specified international financial institutions to take actions to address China's role in such institutions. The representatives to these institutions must (1) advocate and vote against their respective institutions using U.S. contributions to procure goods from (or sourced in) China, and (2) pursue procedural changes so that their respective institutions do not consider China a developing nation for any purpose.
Halting the Use of Narcotics Through Effective Recovery Act of 2022 or the HUNTER Act of 2022 This bill prohibits the use of federal funds to purchase (or support the purchase of) pipes, syringes, or other paraphernalia that can be used to smoke, inject, or otherwise introduce into the body any controlled substance unlawfully. This includes funds made available through the American Rescue Plan Act of 2021 for overdose prevention, syringe services, and other harm reduction programs.
This bill requires the Food and Drug Administration (FDA) to report to Congress on barriers to the domestic manufacturing of imported active pharmaceutical ingredients, finished drug products, and devices that are critical to public health. The report must recommend strategies to overcome such barriers. The FDA may, to the extent appropriate, implement the strategies.
Return to Work Act This bill requires the head of each executive agency to reinstate the telework policies in use by that agency on December 31, 2019.
Stop Funding Our Adversaries Act of 2022 This bill prohibits federal agencies from conducting or supporting, either directly or indirectly, research that will be conducted by China's government, the Chinese Communist Party, or any agent, instrumentality, or entity belonging to or controlled by either entity.
Safeguarding Women's and Children's Health Act of 2022 This bill imposes reporting requirements relating to abortion drugs. The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug. The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events. The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.
